Aarti Drugs Ltd. - Research Center
524348 AARTIDRUGS Group (A) BSE data
Add to watchlist
| Results | |
| Statement |
P&L
|
| More |
Profit loss account
(Rs crore)
| Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | Mar ' 18 | |
|---|---|---|---|---|---|
| Income | |||||
| Operating income | 2,251.17 | 1,914.89 | 1,634.92 | 1,454.25 | 1,140.46 |
| Expenses | |||||
| Material consumed | 1,529.31 | 1,180.83 | 1,081.35 | 994.54 | 727.39 |
| Manufacturing expenses | 258.43 | 203.41 | 197.71 | 166.00 | 142.39 |
| Personnel expenses | 69.32 | 69.29 | 60.10 | 53.14 | 50.49 |
| Selling expenses | 0.35 | 0.27 | 0.70 | 1.40 | 0.41 |
| Adminstrative expenses | 75.58 | 59.82 | 50.66 | 39.89 | 37.93 |
| Expenses capitalised | - | - | - | - | - |
| Cost of sales | 1,932.99 | 1,513.62 | 1,390.51 | 1,254.96 | 958.61 |
| Operating profit | 318.18 | 401.27 | 244.41 | 199.30 | 181.84 |
| Other recurring income | 4.77 | 6.42 | 1.06 | 2.51 | 1.17 |
| Adjusted PBDIT | 322.96 | 407.69 | 245.47 | 201.81 | 183.02 |
| Financial expenses | 20.07 | 22.61 | 32.20 | 37.56 | 33.01 |
| Depreciation | 47.39 | 47.60 | 46.67 | 40.39 | 37.80 |
| Other write offs | - | - | - | - | - |
| Adjusted PBT | 255.50 | 337.49 | 166.60 | 123.86 | 112.21 |
| Tax charges | 60.50 | 80.00 | 39.30 | 40.37 | 38.80 |
| Adjusted PAT | 195.00 | 257.49 | 127.30 | 83.49 | 73.41 |
| Non recurring items | - | 0.22 | 8.38 | 3.77 | - |
| Other non cash adjustments | - | - | - | - | - |
| Reported net profit | 195.00 | 257.71 | 135.67 | 87.26 | 73.41 |
| Earnigs before appropriation | 899.26 | 823.23 | 610.75 | 486.62 | 402.23 |
| Equity dividend | 9.26 | 23.30 | 5.55 | 1.87 | 1.90 |
| Preference dividend | - | - | - | - | - |
| Dividend tax | - | - | 1.44 | 0.48 | 0.49 |
| Retained earnings | 890.00 | 799.93 | 603.76 | 484.26 | 399.84 |
© 2023 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis